1-3 of 3
Emanuele Cilia
Close
Sort by
Journal Articles

Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers

Serena Pillozzi, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei, Marinella Veltroni, Massimo D'Amico, Giuseppe Basso, Andrea Becchetti, Dario Campana, Annarosa Arcangeli
Journal: Blood
Blood (2011) 117 (3): 902–914.
https://doi.org/10.1182/blood-2010-01-262691
Published: 2011
Includes: Supplemental data
Journal Articles

Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels.

Serena Pillozzi, Marika Masselli, Emanuele De Lorenzo, Emanuele Cilia, Olivia Crociani, Amedeo Amedei, Benedetta Accordi, Ph.D., Marinella Veltroni, Giuseppe Basso, Dario Campana, MD, PhD, Andrea Becchetti, Annarosa Arcangeli, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3085.
https://doi.org/10.1182/blood.V114.22.3085.3085
Published: 2009
Journal Articles

Treatment with hERG1 K + Channel Inhibitors Reduces Acute Myeloid Leukemia Cell Lines Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice and Prolongs Survival of Injected Mice.

Serena Pillozzi, Emanuele De Lorenzo, Marika Masselli, Olivia Crociani, Emanuele Cilia, Eugenio Torre, Antonio Mugnai, Andrea Becchetti, Annarosa Arcangeli
Journal: Blood
Blood (2007) 110 (11): 877.
https://doi.org/10.1182/blood.V110.11.877.877
Published: 2007